ASCORBIC ACID Tablet Ref.[7391] Active ingredients: Vitamin C

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2018  Publisher: Ennogen Pharma Limited, Unit G4, Riverside Industrial Estate, Riverside Way, Dartford, DA1 5BS

Therapeutic indications

Prevention and treatment of scurvy.

Posology and method of administration

Posology

Adults and children over 6 years

Prophylactic: 25–75 mg daily.

Note: This unit dosage form is unsuitable for prophylactic use.

Therapeutic: Not less than 250mg daily in divided doses. Maximum of 1000mg daily.

Children under 6 years

This unit dosage form is unsuitable for children under 6 years.

Elderly

As for other adults. As the dietary intake of vitamin C may be less in the elderly, they have greater risk of presenting with vitamin C deficiency.

Method of administration

For oral administration.

Overdose

Symptoms

At doses of over 3g per day unabsorbed ascorbic acid is mainly excreted unmetabolised in the faeces. Absorbed ascorbic acid additional to the body’s needs is rapidly eliminated. Large doses of ascorbic acid may cause diarrhoea and the formation of renal oxalate calculi. Symptomatic treatment may be required.

Ascorbic acid may cause acidosis or haemolytic anaemia in certain individuals with a deficiency of glucose 6-phosphate dehydrogenase. Renal failure can occur with massive ascorbic acid overdosage.

Management

Gastric lavage may be given if ingestion is recent otherwise general supportive measure should be employed as required.

Shelf life

Shelf life

Plastic containers: 3 years.

Blister packs: 2 years.

Special precautions for storage

Plastic containers: Keep the container tightly closed to protect from light and moisture.

Blister packs: Keep the blister in the outer carton to protect from light and moisture.

Nature and contents of container

1. Opaque plastic containers (securitainers) fitted with plastic caps with a packaging inclusion of a silica gel desiccant pack.

Pack sizes are 28, 30, 42, 50, 56, 60, 84, 90, 100, 112, 250, 500 or 1000 tablets.

2. Opaque plastic containers composed of either high density polypropylene or high density polyethylene with a tamper-evident or child-resistant tamper-evident closure composed of high density polyethylene with a packing inclusion of standard polyether foam or polyethylene or polypropylene-made filler and a silica desiccant pack.

Pack sizes are 28, 30, 42, 50, 56, 60, 84, 90, 100, 112, 250, 500 or 1000 tablets.

3. Blister packs of aluminium/opaque PVC/PVDC packed in printed boxboard cartons.

Pack sizes are 28, 30, 56, 60, 84, 90 and 112 tablets.

Not all pack sizes may be marketed.

Special precautions for disposal and other handling

No special instructions.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.